Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
International N&H Usa Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is managed by 1 distinct examiner, GEMBEH, SHIRLEY V, who is the busiest examiner with 1 pending office action. The prosecution is located in 1 distinct art unit. The outcome of the company's current application depends on the specific examination conducted by GEMBEH, SHIRLEY V.
The assignment of 1 distinct examiner to the 1 pending office action means there is no internal comparison available for examiner behavior within this portfolio. Strategy must be developed around the specific tendencies of GEMBEH, SHIRLEY V within the Biotechnology & Pharmaceuticals field. The concentration in 1 distinct art unit suggests a stable procedural framework for this single pending matter.
With 1 pending office action and 1 distinct examiner, the company's prosecution is entirely centralized. This lack of diversity among examiners or art units places a high priority on the specific interactions with GEMBEH, SHIRLEY V. Practitioners should note that the 1 distinct art unit will dictate the timelines and administrative requirements for the entirety of the current pending workload.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GEMBEH, SHIRLEY V | 1 | 63.1% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691680 | A FILM-FORMING COMPOSITION COMPRISING PECTIN | GEMBEH, SHIRLEY V | 38d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691680 | A FILM-FORMING COMPOSITION COMPRISING PECTIN | GEMBEH, SHIRLEY V | 38d overdue |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691680 | A FILM-FORMING COMPOSITION COMPRISING PECTIN | GEMBEH, SHIRLEY V | 1615 | §102§103 | Final Rejection | 38d overdue | Pending | Mar 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInternational N&H Usa Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Shirley V Gembeh has the most, with 1 of International N&H Usa Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.